Completion of the Pivotal Phase 3 Trial for Olanzapine LAI in Schizophrenia
February 10, 2025
Medincell to Join the Euronext SBF 120 Index
December 12, 2024
[Replay] Videoconference – H1 2024-25 Results
December 10, 2024
Consolidated Half-Year Financial Results
December 10, 2024
Medincell and AIC Unveil New Positive Phase 3 Results for mdc-CWM
December 9, 2024
